SCHEMBL4347692

SCHEMBL4347692

CCOC(=O)CCNC(=O)Nc1ccc(O)cc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA7 P43166 2/20 0.44
CA9 Q16790 2/20 0.44
CA14 Q9ULX7 2/20 0.44
KDM4E B2RXH2 4/20 0.44
HTT P42858 2/20 0.44
CXCR1 P25024 1/20 0.44
PTPN7 P35236 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ITGB3 P05106 1/20 0.41
ITGAV P06756 1/20 0.41
HPGD P15428 3/20 0.41
HSD17B10 Q99714 2/20 0.41
MAPT P10636 2/20 0.41
EGFR P00533 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6565685 0.90 CXCR2 (0.50) ALDH1A1KDM4EHTTPTPN7MEN1
SCHEMBL8194387 0.83 MAPT (0.58) ALDH1A1KDM4EHTTCXCR1MEN1
SCHEMBL4349661 0.80 MEN1 (0.67) ALDH1A1KDM4EHTTMEN1KMT2A
SCHEMBL28784043 0.79 POLB (0.56) ALDH1A1HTTCXCR1HPGDMAPT
SCHEMBL4341280 0.78 EPHX2 (0.57) ALDH1A1HTTCXCR1
SCHEMBL4353720 0.77 HTT (0.60) ALDH1A1KDM4EHTTPTPN7MEN1
SCHEMBL14012048 0.75 CXCR1 (0.50) ALDH1A1CA12CA1CA2CA7
SCHEMBL4346935 0.74 ALDH1A1 (0.49) ALDH1A1KDM4EHTTPTPN7MEN1
SCHEMBL4358300 0.74 ALDH1A1 (0.52) ALDH1A1KDM4EHTTPTPN7MEN1
SCHEMBL4358426 0.74 ALDH1A1 (0.43) ALDH1A1KDM4EHTTPTPN7MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
CN-1701061-A Novel compounds for inhibiting rotamase enzymes and uses thereof JERINI AG (DE) 2005-11-23 CN claimed
EP-1539683-A2 PHENOL DERIVATIVES AND THEIR USE AS ROTAMASE INHIBITORS Jerini AG (DE) 2005-06-15 EP claimed
WO-2004030664-A2 NEW COMPOUNDS FOR THE INHIBITION OF UNDESIRED CELL PROLIFERATION AND USE THEREOF JERINI AG (DE) 2004-04-15 WO claimed
WO-2004026815-A2 PHENOL DERIVATIVES AND THEIR USE AS ROTAMASE INHIBITORS JERINI AG (DE) 2004-04-01 WO claimed
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US disclosed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 ALDH1A1 2565/4885CA12 2054/4885CA1 374/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 ALDH1A1 2767/4885CA12 2458/4885CA1 532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.